AVITA Medical, Inc. Income Statement
RCEL|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
AVITA Medical, Inc. reported $64M in revenue and $62M in net loss for FY2025. Revenue has grown at a 133.3% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $64.3M | $50.1M | $34.4M | $29.2M | $5.5M | $929.0K |
| Cost of Revenue | $9.1M | $7.8M | $6.0M | $5.9M | $1.3M | $546.0K |
| Gross Profit | $55.2M | $42.4M | $28.4M | $23.3M | $4.2M | $383.0K |
| SG&A Expense | $33.2M | $28.3M | $23.3M | $22.4M | $15.1M | $9.4M |
| R&D Expense | $20.4M | $20.8M | $13.9M | $14.8M | $8.0M | $6.3M |
| Operating Income | -$56.6M | -$42.7M | -$27.5M | -$26.5M | -$25.5M | -$13.8M |
| Interest Expense | $5.4M | $1.1M | $16.0K | $22.0K | $27.0K | $21.0K |
| Income Tax | $54.0K | $66.0K | $36.0K | $38.0K | -$121.0K | -$1.1M |
| Net Income | -$61.8M | -$35.4M | -$26.7M | -$26.6M | -$25.1M | -$12.7M |
| EPS (Basic) | -$2.39 | -$1.40 | $1.07 | $1.17 | $1.56 | $1.37 |
| EPS (Diluted) | -$2.39 | -$1.40 | $1.07 | $1.17 | $1.56 | $1.37 |
| Shares Outstanding | 26.4M | 25.7M | 25.2M | 24.9M | 21.5M | 18.7M |
| Gross Margin | 85.9% | 84.5% | 82.5% | 79.7% | 76.8% | 41.2% |
| Operating Margin | -88.1% | -85.1% | -79.9% | -90.8% | -466.4% | -1489.9% |
| Profit Margin | -96.3% | -70.6% | -77.5% | -90.9% | -458.6% | -1370.8% |